$56.83
0.080.14%
At close: -
$56.83
0.000.00%
After Hours: Dec 20, 4:04 PM EDT
Comments
Loading...
Janux Therapeutics (NASDAQ:JANX) Stock, Insider Trading Activity
Janux Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Janux Therapeutics Inc Insiders Doing?
At Janux Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 40.00K shares worth $2.29M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On October 22, 2024, RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, RA Capital Nexus Fund II LP, Peter Kolchinsky, Rajeev Shah, the company's DIRECTOR purchased 1.2M shares for $44.75 each.
- On September 27, 2024, Thomas DiRaimondo, the company's CHIEF SCIENTIFIC OFFICER sold 5K shares for $46.34 each.
- On December 3, 2024, Alan David Campbell, the company's PRESIDENT AND CEO sold 15K shares for $67 each.
Ownership Statistics for Janux Therapeutics Inc
Shares Outstanding
58.633M
Insider Shares Owned
908.597K
Insider Percentage Owned
1.73%
Institutional Shares Held
19.542M
Institutional Percentage Held
37.2%
Data brought to you by Benzinga APIs
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.